|
1
|
Liu C and Lin J: Long noncoding RNA
ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically
activating ZEB1. Am J Transl Res. 8:4095–4105. 2016.PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Daw NC, Chou AJ, Jaffe N, Rao BN, Billups
CA, Rodriguez-Galindo C, Meyers PA and Huh WW: Recurrent
osteosarcoma with a single pulmonary metastasis: A
multiinstitutional review. Br J Cancer. 112:278–282. 2012.
View Article : Google Scholar
|
|
4
|
Yu L, Liu S, Guo W, Zhang C, Zhang B, Yan
H and Wu Z: hTERT promoter activity identifies osteosarcoma cells
with increased EMT characteristics. Oncol Lett. 7:239–244. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sung JY, Park SY, Kim JH, Kang HG, Yoon
JH, Na YS, Kim YN and Park BK: Interferon consensus
sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal
transition (EMT)-like phenomena, cell-motility, and invasion via
TGF-β signaling in U2OS cells. Cell Death Dis. 5:e12242014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al-Khalaf HH and Aboussekhra A:
MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic
mesenchymal characteristics through the RNA-binding protein AUF1
targeting the transcription factor ZEB1 and the protein kinase AKT.
J Biol Chem. 289:31433–31447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Putzke AP, Ventura AP, Bailey AM, Akture
C, Opoku-Ansah J, Celiktaş M, Hwang MS, Darling DS, Coleman IM,
Nelson PS, et al: Metastatic progression of prostate cancer and
e-cadherin regulation by zeb1 and SRC family kinases. Am J Pathol.
179:400–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roy BC, Kohno T, Iwakawa R, Moriguchi T,
Kiyono T, Morishita K, Sanchez-Cespedes M, Akiyama T and Yokota J:
Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of
human lung cancer cells. Lung Cancer. 70:136–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen A, Zhang Y, Yang H, Xu R and Huang G:
Overexpression of ZEB1 relates to metastasis and invasion in
osteosarcoma. J Surg Oncol. 105:830–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen LL and Zhao JC: Functional analysis
of long noncoding RNAs in development and disease. Adv Exp Med
Biol. 825:129–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu HY, Bai WD, Li C, Zheng Z, Guan H, Liu
JQ, Yang XK, Han SC, Gao JX, Wang HT and Hu DH: Knockdown of
lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting
ZNF217 via miR-200c in keloid fibroblasts. Sci Rep. 6:247282016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu X, He X, Li S, Xu X, Chen X and Zhu H:
Long non-coding RNA ucoo2kmd.1 regulates CD44-dependent cell growth
by competing for miR-211-3p in colorectal cancer. PLoS One.
11:e01512872016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang GQ, Wang Y, Xiong Y, Chen XC, Ma ML,
Cai R, Gao Y, Sun YM, Yang GS and Pang WJ: Sirt1 AS lncRNA
interacts with its mRNA to inhibit muscle formation by attenuating
function of miR-34a. Sci Rep. 6:218652016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishii N, Ozaki K, Sato H, Mizuno H, Saito
S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, et al:
Identification of a novel non-coding RNA, MIAT, that confers risk
of myocardial infarction. J Hum Genet. 51:1087–1099. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Crea F, Venalainen E, Ci X, Cheng H, Pikor
L, Parolia A, Xue H, Saidy Nur NR, Lin D, Lam W, et al: The role of
epigenetics and long noncoding RNA MIAT in neuroendocrine prostate
cancer. Epigenomics. 8:721–731. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sha M, Lin M, Wang J, Ye J, Xu J, Xu N and
Huang J: Long non-coding RNA MIAT promotes gastric cancer growth
and metastasis through regulation of miR-141/DDX5 pathway. J Exp
Clin Cancer Res. 37:582018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan H, Zhang B, Fang C and Chen L: miR-340
alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Anticancer Drugs. 29:440–448. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li
YJ, Tao ZF, Song YC, Chen Q and Jiang Q: LncRNA-MIAT regulates
microvascular dysfunction by functioning as a competing endogenous
RNA. Circ Res. 116:1143–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin M, Yang Z, Ye W, Xu H and Hua X:
MicroRNA-150 predicts a favorable prognosis in patients with
epithelial ovarian cancer, and inhibits cell invasion and
metastasis by suppressing transcriptional repressor ZEB1. PLoS One.
9:e1039652014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lulla RR, Costa FF, Bischof JM, Chou PM,
de F Bonaldo M, Vanin EF and Soares MB: Identification of
differentially expressed MicroRNAs in osteosarcoma. Sarcoma.
2011:7326902011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Orom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barnhill LM, Williams RT, Cohen O, Kim Y,
Batova A, Mielke JA, Messer K, Pu M, Bao L, Yu AL and Diccianni MB:
High expression of CAI2, a 9p21-embedded long noncoding RNA,
contributes to advanced-stage neuroblastoma. Cancer Res.
74:3753–3763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun
M, Xia R and Lu KH: Long non-coding RNA MVIH indicates a poor
prognosis for non-small cell lung cancer and promotes cell
proliferation and invasion. Tumour Biol. 35:7587–7594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhen L, Yun-Hui L, Hong-Yu D, Jun M and
Yi-Long Y: Long noncoding RNA NEAT1 promotes glioma pathogenesis by
regulating miR-449b-5p/c-Met axis. Tumour Biol. 37:673–683. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He Y, Jiang X and Chen J: The role of
miR-150-5p in normal and malignant hematopoiesis. Oncogene.
33:3887–3893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Ren Y, Wang Z, Xiong X, Han S, Pan
W, Chen H, Zhou L, Zhou C, Yuan Q and Yang M: Down-regulation of 5S
rRNA by miR-150-5p and miR-383 enhances c-Myc-rpL11 interaction and
inhibits proliferation of esophageal squamous carcinoma cells. FEBS
Lett. 589:3989–3997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu DZ, Zhang HY, Long XL, Zou SL, Zhang
XY, Han GY and Cui ZG: MIR-150-5P promotes prostate cancer stem
cell development via suppressing p27Kip1. Eur Rev Med Pharmacol
Sci. 19:4344–4352. 2015.PubMed/NCBI
|
|
30
|
Li J, Hu L, Tian C, Lu F, Wu J and Liu L:
microRNA-150 promotes cervical cancer cell growth and survival by
targeting FOXO4. BMC Mol Biol. 16:242015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qu Y, Pan S, Kang M, Dong R and Zhao J:
MicroRNA-150 functions as a tumor suppressor in osteosarcoma by
targeting IGF2BP1. Tumor Biol. 37:5275–5284. 2016. View Article : Google Scholar
|
|
32
|
Luan T, Zhang X, Wang S, Wang S, Song Y,
Zhou S, Lin J, An W, Yuan W, Yang Y, et al: Long non-coding RNA
MIAT promotes breast cancer progression and functions as ceRNA to
regulate DUSP7 expression by sponging miR-155-5p. Oncotarget.
8:76153–76164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao M, Hou D, Liang H, Gong F, Wang Y, Yan
X, Jiang X, Wang C, Zhang J, Zen K, et al: miR-150-5p promotes the
proliferation and proliferation of lung cancer cells by targeting
SRC kinase signalling inhibitor 1. Eur J Cancer. 50:1013–1024.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Zhan Q, Deng X, Chen H, Shen B, et al: miR-150-5p-5p inhibits
hepatoma cell proliferation and invasion by targeting MMP14. PLoS
One. 9:e1155772014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Preca BT, Bajdak K, Mock K, Sundararajan
V, Pfannstiel J, Maurer J, Wellner U, Hopt UT, Brummer T, Brabletz
S, et al: A self-enforcing CD44S/ZEB1 feedback loop maintains EMT
and stemness properties in cancer cells. Int J Cancer.
137:2566–2577. 2015. View Article : Google Scholar : PubMed/NCBI
|
